Insider · CIK 0001350090
Jonathan I Lieber
Files at DCOY (Salarius Pharmaceuticals, Inc.), RLYB (Rallybio Corp). First filing Feb 23, 2026, latest Feb 23, 2026.
In brief
Jonathan I Lieber files SEC Form 4 as director and CFO at RLYB (Rallybio Corp), and also at DCOY (Salarius Pharmaceuticals, Inc.). Since Feb 23, 2026, Jonathan I Lieber has reported 0 open-market buys worth $0 and 1 open-market sell worth $3,992, the latest filed on Feb 23, 2026.
A track record needs three past buys with six months of prices behind them; Jonathan I Lieber has 0, so none is measured yet.
The newest scored trade: sold $3,992 of RLYB on Feb 23, 2026, filed Feb 23, 2026, scored 27 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $3,992.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RLYB: Rallybio Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | RLYB Rallybio Corp | MOption exercise Common Stock | +5,000 | $6.08 | $30k | 9,740 | 12 d ago |
| Sep 29, 2026 | RLYB Rallybio Corp | MOption exercise Option (Right to Buy)derivative | -5,000 | $0.00 | $0 | 0 | 12 d ago |
| Aug 31, 2026 | DCOY Salarius Pharmaceuticals, Inc. | AGrant or award Common Stock | +2,000 | $0.00 | $0 | 2,002 | 41 d ago |
| Feb 18, 2026 | RLYB Rallybio Corp | AGrant or award Common Stock | +2,500 | $0.00 | $0 | 4,904 | Feb 23, 2026 |
| Feb 23, 2026 | RLYB Rallybio Corp | SOpen-market sale Common Stock | -789 | $5.06 | $3,992 | 4,115 | Feb 23, 2026 |
Questions about Jonathan I Lieber
Answered from the filings on this page, as of the latest one.
Is Jonathan I Lieber buying or selling?
In the last 12 months Jonathan I Lieber reported 0 open-market buys worth $0 and 1 open-market sell worth $3,992 on SEC Form 4; the latest was sold $3,992 of RLYB on Feb 23, 2026. Grants, option exercises and tax withholding are not counted.
How did Jonathan I Lieber's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jonathan I Lieber has 0.
Where does Jonathan I Lieber file Form 4?
Jonathan I Lieber has filed Form 4 at RLYB (Rallybio Corp) as Chief Financial Officer; DCOY (Salarius Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.